SFARI Explorer Awards

Sponsor:

Simons Foundation Autism Research Initiative (SFARI)

Deadline:

Applications are considered on a rolling basis, with a response time as early as 30 days.

Summary:

This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.

Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.

Eligibility:

All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.

Available Funding:

The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.

Link to Full RFP:

https://sfari.org/funding/grants/explorer-awards-rfa

Integration of Individual Residential Histories into Cancer Research (R21) PA-17-295 and (R01) PA-17-298

Sponsor:

NIH / NCI

Deadline:

Standard R01 dates apply

Standard R21 dates apply

Summary:

The purpose of this Funding Opportunity Announcement (FOA) is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes, and to encourage the development of complex analytical strategies in support of substantive investigation.

There is a growing recognition of the importance of residential histories – a record of an individual’s places of residence across his or her lifetime — in cancer research, as part of evolving cancer data ecosystem.  Residential history encapsulates a person’s multiple interactions with the social and physical environment that can result in lasting health impact and is an important factor in assessing the effects of exposures on disease onset, as demonstrated in focused studies.  Lifetime residential history records can reveal the variety of potential and actual exposures throughout person’s life including, but not limited to: neighborhood characteristics, physical conditions of housing, tobacco and alcohol consumption, food environments, chemical exposures to contaminants in water, soil, and air, accessibility to healthcare resources, and health disparities.

This FOA is expected to engage scientists from a range of disciplines, including epidemiology, statistics, geospatial science, computer science, demography, decision science, and behavioral science, to effectively integrate individual residential histories into cancer research.

Geospatial expertise is essential for generating new knowledge about the residential context relative to cancer risk, etiology, prevention, treatment, and outcomes. Computer science and informatics are crucial for the development of methodology that would ensure more precise matching of residential information and location (geocoding), improve linkage to automated data sources, and generate reliable lifetime residential histories. Cancer surveillance science, in conjunction with statistical, epidemiological, and medical expertise, is extremely important in answering substantial questions related to the use of lifetime residential histories in the analysis of cancer risk and cancer burden.

In addition, a combination of scientific expertise in demography and behavioral science in addressing the role of lifetime residential histories in the context of cancer can help facilitate more precise assessment of cancer disparities.

Eligibility:

N/A

Available Funding:

R01: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

R21: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year. The maximum project period is 2 years.

Link to Full RFP:

R01https://grants.nih.gov/grants/guide/pa-files/PA-17-298.html

R21https://grants.nih.gov/grants/guide/pa-files/PA-17-295.html

Socioeconomic Disparities in Health and Mortality at Older Ages (R01) (RFA-AG-18-011)

Sponsor:

National Institute on Aging

Deadline:

October 20, 2017

Summary:

The purpose of this funding opportunity is to support studies that identify mechanisms, explanations, and modifiable risk factors underlying recent trends of growing inequalities in morbidity and mortality by income, education, and geographic location at older ages in the United States. Applicants are encouraged to consider a variety of health outcomes in order to explain the processes generating these trends. Applicants are strongly encouraged to present well-developed conceptual models.

Examples of analytic approaches that fall within the scope of this FOA include (but are not limited to) those that:

  • Identify the mechanisms that explain growing socioeconomic and geographic inequalities in health at older ages, explain their role in racial disparities, and detect modifiable risk factors
  • Ascertain the extent to which these trends are driven by age, period, and cohort-related factors
  • Consider the role of education, income, and geographic region as causal factors versus alternative explanations such as differential selection over time or shifting composition of groups
  • Leverage longitudinal data, ideally from childhood through old age
  • Use a diverse set of analytic methods (e.g. life-cycle, comparative, cohort, multi-level)
  • Consider how institutional and cultural contexts (including their timing within the life course of individuals) influence health disparities
  • Examine a wide range of physical, mental, and functional health outcomes, in addition to mortality
  • Capitalize on NIA-funded data sources with life history and geographic information (e.g., English Longitudinal Study of Ageing; Health and Retirement Study; Midlife in the United States; National Longitudinal Mortality Study; Panel Study of Income Dynamics; Survey of Health, Ageing, and Retirement in Europe)

Examples of data improvements that fall within the scope of this FOA include (but are not limited to) those that:

  • Enhance existing data resources to improve data availability on a variety of topics (e.g., early life development, exposures to inequality prior to midlife, comprehensive stress measurements, employer and work issues, and minority groups) to enable examination of within-group heterogeneity
  • Enhance existing clinical studies to add complementary measures in areas such as social, emotional, and psychological domains

Characteristics of Responsive Applications

1. Life course approaches are encouraged, but applications proposing analysis of data solely from childhood or young adulthood are not responsive to this FOA.

2. Applications that document descriptive trends without assessing potential mechanisms or explanations will not be considered responsive.

3. Applications proposing projects that use only animal models are not responsive to this FOA. 

Eligibility:

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

Available Funding:

The National Institute on Aging intends to commit $2 million in total costs in FY 2018 to fund 3-6 awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Link to Full RFP:

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-011.html

Multi-discipline and Systemic Caring for the Woman Experiencing Menopause: Innovative Decision Making Tools

Sponsor:

Pfizer Independent Grants for Learning & Change

Deadline:

July 12, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to support optimal and/or appropriate practice interventions regarding care and treatment of women experiencing menopause. Projects should focus on educational resources (e.g. patient-physician shared decision-making tools /innovative apps) to support effective identification of the need for therapeutic intervention and appropriate selection of therapeutic intervention based on presentation.

  • The learning and change strategy should address helping improve the care of women with menopause by:
  • Improving symptom identification (by patients or physicians)
  • Improving care systems that showcase and operationalize the wellness visit as a focus for menopausal care

Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment The educational initiative should be focused on primary care practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and all other specialists who care for the menopausal woman. Proposals whose educational model is broadly applicable for use in other settings and/or used for resident education will be rated favorably.

In addition, proposals that include the following elements are of interest:

  • Completed within a 12 month timeframe
  • Developing durable tools, materials (e.g. >1 one time use)
  • Intraprofessional collaboration among organizations
  • Incorporating the patient perspective
  • Innovative in terms of approach and output
  • Robust outcomes plan that reflects optimization of care metrics

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.

Projects that focus on live annual meetings, regional conferences, and speaker series are out of scope.

Eligibility:

Project  must be based in the United States.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH2_MenopausalCare.v.2.pdf

Addressing Attitudes, Beliefs, and Cultural Barriers in Women’s Health Decision-Making

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 26, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to understand the role of patient attitudes, beliefs, and cultural barriers in women’s health decision-making during reproductive and post-reproductive health care. These factors have a major influence and variations exist globally for women during life events including family planning and menopause related issues. The learning and change strategy should address techniques to overcome barriers in improving the care of women during family planning and/or menopause by:

  • Improving care systems that showcase and operationalize the wellness visit
  • Innovating the patient-physician dialogue (e.g. ‘difficult conversations’)
  • Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment
  • Dispelling common patient myths and misconceptions.

The educational initiative should be focused on primary care practitioners including general practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and/or other specialists who care for women in the reproductive phase of their lives, menopausal women, or all. Proposals whose educational model is broadly applicable for use in varied settings and/or used for trainee education will be rated favorably.

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.  

Eligibility:

Project must be global in scope.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH1_WomensHealth.v.2.pdf

Addressing Education in Relation to Tobacco Dependence Treatment in France

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 31, 2017

Summary:

It is our intent to support programs that strive to increase the number of patients who stop smoking by improving the frequency and effectiveness of healthcare professional smoking cessation interventions. This CGA is to encourage academic and healthcare organisations to submit applications focused on educating healthcare professionals on the latest clinical data-driven updates in tobacco dependence treatments. Applications focusing on one or more of the following criteria will be given preference:

  • Educating physicians to initiate smoking cessation discussions with patients and to promote the health benefits of smoking cessation
  • Educating physicians about the importance of initiating smoking cessation therapy
  • Increasing physician awareness of the available treatment and support mechanisms required for smoking cessation
  • Educating physicians about the importance of ensuring appropriate follow-up with patients following initiation of smoking cessation treatment/counselling to ensure compliance

While programming targeted at addressing knowledge gaps may involve live sessions, efforts should be made to encourage interaction and provide opportunities to extend learning opportunities beyond the live setting. In addition to live programs, technology-enabled distance learning with facilitated interactive components, online courses, and other enduring materials may also be proposed.

Eligibility:

Geographic scope is France only.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. However, please note that priority will be given to applications from non-profit academic and healthcare organisations.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $50,000 will be considered. The total available budget related to this CGA is $150,000.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17SC1_SmokingCessation.pdf

Clinical Trial Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required): July 20, 2017

Application (by invitation only): October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proofof-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of the military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required.

Eligibility:

  • PIs at or above the level of Assistant Professor (or equivalent) are eligible to submit applications.
  • Funding from this award mechanism must support a clinical trial. Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Funding limit not defined; requested funding must be appropriate for the scope of work proposed/Maximum period of performance is 4 years

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-CTA.pdf

Discovery Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 19, 2017

Application (by invitation only):  August 2, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The intent of the PRMRP Discovery Award is to support innovative, non-incremental, highrisk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a wellformulated, testable hypothesis based on a sound scientific rationale and study design.

The outcome of research supported by this award should be the generation of preliminary data that can be used as a foundation for future research projects to understand the mechanisms of initiation or progression and/or improving patient care for a disease or condition.

Eligibility:

  • Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above are eligible to submit applications.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Maximum of $200,000 for direct costs (plus indirect costs)/ Maximum period of performance is 18 months

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-DA.pdf

Focused Program Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 20, 2017

Application (by invitation only):  October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas. The PRMRP Focused Program Award mechanism is intended to optimize research and accelerate the solution for a critical question.

  • Projects must support a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal.
  • Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
  • Projects may range from exploratory/ hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.
  • Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.

Eligibility:

  • The PI must be an independent investigator at or above the level of Full Professor (or equivalent).
  • The PI is required to devote a minimum of 20% effort to this award.
  • Project leaders for each of the complementary and synergistic research projects must be at or above the level of Assistant Professor (or equivalent).
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

The anticipated total costs budgeted for the entire period of performance will not exceed $10M / maximum period of performance is 4 years.

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-FPA.pdf

POST-DOCTORAL TRAINING SUPPORT PROGRAM IN CLINICAL AND TRANSLATIONAL RESEARCH (TL1)

Sponsor:

Clinical and Translational Science Institute (CTSI)

Deadline:

5PM on June 27, 2017

Summary:

The TL1 offers support, mentoring and training opportunities for late-stage pre-doctoral and early-stage post-doctoral scholars conducting research in the area of health care and/or translational medicine. The program provides stipends, training and mentoring while emphasizing the scholar’s success within their established research area. The fundamental goal of the program is to help and support scholars as they advance in their research careers, and to provide them with the knowledge and skills to eventually develop into successful, independent researchers. The program encourages productivity, collaborative research and career development.

Eligibility:

Late-stage pre-doctoral PhD students who have completed required coursework, as well as early stage post-doctoral research scholars (1-2 years after completion of pre-doctoral training) are eligible to apply. Post-doctoral scholars should be actively engaged in translationally-relevant research. Scholars from any unit or school in the University, or with appointments at CTSI-affiliated New York City Health + Hospitals institutions, are eligible to apply. Applicants must have the support of their research advisor/mentor.

Available Funding:

The TL1 program will provide up to two years of stipend and other support. Based on NIH requirements, the stipend for pre-doctoral candidates will be set at a maximum of $22,920 annually. For post-doctoral scholars, salary will be set at NIH post-graduate year levels (See NIH website: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-048.html). Additional funds will be available for educational courses and travel to meetings. Pre-doctoral scholars who graduate, or post-doctoral scholars who successfully compete for an NIH K or R award or equivalent, will be rotated off the program.

Link to Full RFP:

https://med.nyu.edu/ctsi/training-education/research-career-development/tl1